RemedyRepack Inc. is recalling 8 bottles of Phenazopyridine HCl (100 mg) tablets because they were mislabeled and actually contain Phenobarbital (16.2 mg) tablets. Phenazopyridine is typically used to relieve urinary tract pain, while Phenobarbital is a controlled sedative and anti-seizure medication. The recall affects 6-count bottles from lot B2906961-042524 with an expiration date of 02/26/2027.
Patients taking this mislabeled product will unknowingly ingest Phenobarbital, which can cause unintended sedation, dizziness, or serious central nervous system effects. Additionally, the patient's urinary pain may go untreated, and there is a risk of dangerous drug interactions if the patient is taking other medications.
You have 2 options:
Repackaged by RemedyRepack, Inc. Source product manufactured by Winder Laboratories, LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.